Related Experiment Video
Updated: May 13, 2026
06:28
Standardized Modular Assembly of Polycistronic Operons with Modular Cloning (MoClo) using the In-Cloning toolkit
Published on: September 2, 2025
A highly efficient molecular cloning platform that utilises a small bacterial toxin gene
1Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton Ontario, L8S 4K1, Canada.
Chembiochem : a European Journal of Chemical Biology
|March 21, 2013
Summary
A novel detox cloning system using IbsC toxin variants from Escherichia coli K-12 significantly improves molecular cloning efficiency. This cost-effective method reduces steps and time, achieving over 95% positive clones for high-throughput applications.
Area of Science:
- Molecular Biology
- Biotechnology
Background:
- Traditional molecular cloning methods are often multi-step and rely on expensive enzymes.
- Existing technologies can be labor-intensive and costly, limiting high-throughput applications.
Purpose of the Study:
- To engineer novel cloning vectors using IbsC toxin variants for enhanced molecular cloning.
- To develop a more efficient, cost-effective, and time-saving cloning system.
Main Methods:
- Engineered cloning vectors containing variants of IbsC, a toxin from Escherichia coli K-12.
- Tested the system with reporter gene cloning to assess efficiency and background reduction.
Main Results:
- The IbsC-based detox cloning system consistently yielded over 95% positive clones.
- Eliminated the need for purification steps between digestion and ligation.
- Reduced the total cloning time to as little as three hours from digestion to plating.
Conclusions:
- IbsC-based cloning vectors offer a reliable and efficient alternative to commercial systems.
- This method is amenable to high-throughput cloning, being both time-efficient and cost-effective.
- The engineered vectors minimize background, labor, and costs associated with molecular cloning.
Related Concept Videos
01:33Bacterial Transformation
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
01:26DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
02:53Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...